Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$32.8 million.

  • Kestra Medical Technologies' Income from Continuing Operations fell 5898.84% to -$32.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$131.5 million, marking a year-over-year decrease of 5496.25%. This contributed to the annual value of -$113.8 million for FY2025, which is 2092.44% down from last year.
  • According to the latest figures from Q4 2025, Kestra Medical Technologies' Income from Continuing Operations is -$32.8 million, which was down 5898.84% from -$25.8 million recorded in Q3 2025.
  • Kestra Medical Technologies' Income from Continuing Operations' 5-year high stood at -$20.3 million during Q3 2024, with a 5-year trough of -$51.1 million in Q2 2025.